Maravai LifeSciences Holdings, Inc. (MRVI)
The company now
Maravai LifeSciences Holdings, Inc. is classed by the SEC under Pharmaceutical Preparations (industry code 2834), based in San Diego, CA. In its latest annual figures on file, for the fiscal year ended 2025-12-31, it reported revenue of $186 million and a loss of $131 million (its filed statements).
From its filings and filed figures; the desk's account of it is not written yet.
Where the revenue comes from
fiscal 2025, as filedRevenue by line of business, fiscal 2025
| Line of business | Fiscal 2025 | Fiscal 2024 | Share of revenue |
|---|---|---|---|
| Tri Link | $120M | $196M | 64.5% |
| Cygnus | $66.0M | $62.8M | 35.5% |
Revenue by region, fiscal 2025
| Region | Fiscal 2025 | Fiscal 2024 | Share of revenue |
|---|---|---|---|
| North America | $112M | $127M | 60.5% |
| Asia Pacific | $41.5M | $89.4M | 22.3% |
| Europe, the Middle East and Africa | $30.9M | $42.1M | 16.6% |
| Latin and Central America | $971,000 | $662,000 | 0.5% |
As tagged in its annual report (Form 10-K, filed Feb 26, 2026 ↗), read from the SEC's financial statement data sets. The year before is the figure the record holds for the prior fiscal year.
The desk's written account of this company, its Past, Present and Future, is not on file yet.
How the company works
The desk has not read this company's annual report yet.
The record in brief
The desk has not written this company's report yet.